Centrosomal abnormality is common in and a potential biomarker for bladder cancer

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International Journal of Cancer

• Publication date

  2003-09-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.11251PMID 12866024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Centrosome aberrations: cause or consequence of cancer progression?

  2002cited by this paper
• Centrosome amplification and the development of cancer

  2002cited by this paper
• Centrosome amplification drives chromosomal instability in breast tumor development

  2002cited by this paper
• Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu

  2002cited by this paper
• Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells.

  2001cited by this paper
• Stepwise Progression of Centrosome Defects Associated with Local Tumor Growth and Metastatic Process of Human Pancreatic Carcinoma Cells Transplanted Orthotopically into Nude Mice

  2001cited by this paper
• Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression.

  2001cited by this paper
• Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.

  2001cited by this paper
• Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.

  2001cited by this paper
• Human Papillomavirus Infection, Centrosome Aberration, and Genetic Stability in Cervical Lesions

  2001cited by this paper
• Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations

  2000cited by this paper
• Ancillary methods for the detection of recurrent urothelial neoplasia

  2000cited by this paper
• Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic and extrahepatic bile ducts

  2000cited by this paper
• A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.

  2000cited by this paper
• The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.

  2000cited by this paper
• Centrosome abnormalities in pancreatic ductal carcinoma.

  1999cited by this paper
• Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast.

  1999cited by this paper
• Altered centrosome structure is associated with abnormal mitoses in human breast tumors.

  1999cited by this paper
• Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer

  1998cited by this paper
• Centrosome defects and genetic instability in malignant tumors.

  1998cited by this paper
• Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity.

  1998cited by this paper
• Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

  1998cited by this paper
• Genetic instability of cancer cells is proportional to their degree of aneuploidy.

  1998cited by this paper
• Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.

  1997cited by this paper
• DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma.

  1996cited by this paper
• Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.

  1995cited by this paper
• The origin of malignant tumors

  year unknowncited by this paper

• Estrogens—Origin of Centrosome Defects in Human Cancer?

  2022cites this paper
• Regulatory basis for reproductive flexibility in a meningitis-causing fungal pathogen

  2022cites this paper
• Xeroderma Pigmentosum: A Model for Human Premature Aging.

  2021cites this paper
• KIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer

  2021cites this paper
• Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies

  2020cites this paper
• LKB1 and cancer: The dual role of metabolic regulation.

  2020cites this paper
• Centrosome Abnormalities and Polyploidy in Murine Mammary Carcinomas with Different Degrees of Hormone Responsiveness

  2020cites this paper
• SASS6 promotes proliferation of esophageal squamous carcinoma cells by inhibiting the p53 signaling pathway.

  2020cites this paper
• Microtubule-organizing center-mediated structural atypia in low- and high-grade urothelial carcinoma

  2020cites this paper
• XPC deficiency leads to centrosome amplification by inhibiting BRCA1 expression upon cisplatin-mediated DNA damage in human bladder cancer.

  2019cites this paper
• Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic Targets

  2015cites this paper
• Structural centrosome aberrations favor proliferation by abrogating microtubule-dependent tissue integrity of breast epithelial mammospheres

  2015cites this paper
• Characterising the phosphorylation of YB-1

  2015cites this paper
• LIMK1 regulates centrosome integrity and mitotic spindle positioning

  2015cites this paper
• Understanding the molecular basis of RAS-association domain family member 7 (RASSF7) function

  2015cites this paper
• Liver kinase B1 regulates the centrosome via PLK1

  2014cites this paper
• The Role of LIM Kinase 1 and its Substrates in Cell Cycle Progression

  2014cites this paper
• Centrosome amplification in bladder washing cytology specimens is a useful prognostic biomarker for non-muscle invasive bladder cancer.

  2013cites this paper
• Ellagic acid induces apoptosis in TSGH8301 human bladder cancer cells through the endoplasmic reticulum stress‐ and mitochondria‐dependent signaling pathways

  2013cites this paper
• Mortalin: A Positive Regulator of Centrosome Duplication and Amplification

  2012cites this paper
• ДИАГНОСТИКА И ПРОГНОЗИРОВАНИЕ РЕЦИДИВА НЕМЫШЕЧНО-ИНВАЗИВНОГО РАКА МОЧЕВОГО ПУЗЫРЯ ПРИ ПОМОЩИ КЛИНИЧЕСКИХ МЕТОДОВ И FISH-АНАЛИЗА (ОБЗОР ЛИТЕРАТУРЫ)

  2012cites this paper
• Characterization and expressional analysis of Dleu7 during Xenopus tropicalis embryogenesis.

  2012cites this paper
• Mortalin Biology: Life, Stress and Death

  2012cites this paper
• Funktionelle Charakterisierung genetisch aberranter Karzinomzellen bei Primärkulturen von fortgeschrittenen Harnblasen-Karzinomen

  2011cites this paper
• Overexpression of Active Aurora-C Kinase Results in Cell Transformation and Tumour Formation

  2011cites this paper
• A Clinical Overview of Centrosome Amplification in Human Cancers

  2011influential citation
• Urine from current smokers induces centrosome aberrations and spindle defects in vitro in nonmalignant human cell lines.

  2010cites this paper
• Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors

  2010cites this paper
• Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.

  2008cites this paper
• DNA image cytometry in bladder cancer: state of the art.

  2008cites this paper
• Cytoskeletal defects lead to cytokinesis failure and genomic instability in cancer cells

  2008cites this paper
• Genomic DNA Hypomethylation is a Biomarker for Bladder Cancer Susceptibility in the Spanish Bladder Cancer Case-Control Study

  2008cites this paper
• ヒト膀胱上皮細胞におけるAurora-A遺伝子の過剰発現と中心体の異常複製,染色体異常の研究

  2007cites this paper
• Molecular cytogenetic characterization and diagnostics of bladder cancer.

  2007cites this paper
• UNIVERSITA’ DEGLI STUDI DI TORINO

  2007cites this paper
• Biological Characteristics in Bladder Cancer Depend on the Type of Genetic Instability

  2006cites this paper
• Novel Diagnostic Markers and Prognosticators in Superficıal Bladder Cancer

  2006cites this paper
• Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.

  2006cites this paper
• Yüzeyel Mesane Tümörlerinde Tanısal ve Prognostik Yeni Belirleyiciler

  2006cites this paper
• Origins and consequences of centrosome aberrations in human cancers

  2006cites this paper
• UXT is a novel centrosomal protein essential for cell viability.

  2005cites this paper
• Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.

  2005cites this paper
• Centrosome amplification, chromosome instability and cancer development.

  2005cites this paper
• DNA index determination with Automated Cellular Imaging System (ACIS) in Barrett's esophagus: Comparison with CAS 200

  2005cites this paper
• RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells

  2005cites this paper
• Centrosome Hyperamplification Predicts Progression and Tumor Recurrence in Bladder Cancer

  2004influential citation
• New molecular markers for bladder cancer detection

  2004cites this paper
• Centrosomes--their role in tumors and cancer therapy.

  2004cites this paper